Skip to main content

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Erratum to: Cardiovascular Diabetology (2015) 14:31 DOI 10.1186/s12933-015-0195-2

After publication of the original article, it came to our attention that the samples used for the MMPs and TIMP-1 measurements were serum samples instead of plasma samples. Therefore,

  1. 1.

    Plasma levels of MMPs and TIMP-1 in the title, abstract, methods, results and discussion section should read serum levels; and

  2. 2.

    In the discussion section the sentence, “Possibly the serum measurement does not truly reflect the circulating concentration of MMPs and TIMPs compared to the plasma measurement” should be disregarded.

We apologize for any inconvenience.

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Coen D Stehouwer.

Additional information

The online version of the original article can be found under doi:10.1186/s12933-015-0195-2.

Rights and permissions

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Peeters, S.A., Engelen, L., Buijs, J. et al. Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol 14, 128 (2015). https://doi.org/10.1186/s12933-015-0290-4

Download citation